Canton Barry's Form 4 filing
Ginkgo Bioworks Holdings, Inc. (DNA) · filed Jan 10, 2023
- Accession no.
- 0001127602-23-001235
- Filed
- Jan 10, 2023
- Trade date
- Jan 6-9, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $915.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Canton BarryCIK 0001882756 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2023 | Class A Common Stock | SSaleDisposed | −152,094 | $1.49 | −$226,620.06 | 17,453,403 | Direct | |
| Jan 6, 2023 | Class A Common Stock | SSaleDisposed | −152,094 | $1.49 | −$226,620.06 | 17,453,409 | Indirect | |
| Jan 9, 2023 | Class A Common Stock | SSaleDisposed | −152,159 | $1.52 | −$231,281.68 | 17,301,244 | Direct | |
| Jan 9, 2023 | Class A Common Stock | SSaleDisposed | −152,159 | $1.52 | −$231,281.68 | 17,301,250 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.